How peptide therapy is prescribed, sourced and monitored

It starts with a clinical review

Before anything is prescribed, a clinician needs your medical history, current medicines and supplements, allergies and goals. Some conditions change the picture entirely: active or past cancer, pregnancy plans, uncontrolled blood pressure, heart disease or kidney problems.

Labs often play a role. Thyroid, iron, blood sugar and sex hormone results can reveal a more likely cause of your symptoms. For peptides that act on the growth hormone axis, a baseline IGF-1 gives a reference point, since MedlinePlus notes IGF-1 is a more stable measure of growth hormone activity than growth hormone itself.

A clinical decision, not a product choice

The clinician weighs what the evidence shows for your goal, the peptide's regulatory status, your risk factors and simpler alternatives. That might lead to a peptide, a different treatment or no prescription at all.

If a peptide is chosen, the clinician picks the product, form, starting dose and schedule, and explains how you'll judge whether it's working. HealifyMD doesn't publish home dosing protocols for compounded peptides, because doses should be set for the individual.

Where the medicine comes from

Approved peptide drugs are dispensed like any other prescription. Many other peptides are compounded. Under section 503A, a licensed pharmacy compounds a medicine for an individual patient based on a prescription. State boards of pharmacy provide most day-to-day oversight of these pharmacies, and the FDA can inspect them.

Outsourcing facilities, registered under section 503B, are a separate category that the FDA inspects and holds to manufacturing quality standards. Either way, compounded drugs are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before use. That's why knowing exactly which pharmacy fills your prescription matters.

The regulatory check

Not every peptide can be lawfully compounded, and the rules have been changing. In 2026 several popular peptides moved off the FDA's significant-safety-risk category after their nominations were withdrawn, and an FDA advisory committee later recommended six for the 503A bulks list. As of October 2026, the FDA had not finalized that rulemaking.

HealifyMD only arranges a prescription when a licensed pharmacy confirms it can lawfully dispense the product under current federal and state rules. Your clinician will tell you the status of the specific peptide you're considering.

Responsible versus risky

• Responsible: a named, licensed clinician reviews your history. Risky: you pick a product and dose from a website.
• Responsible: the prescription is written for you and filled by a licensed pharmacy you can identify. Risky: the product is labeled "research use only" or "not for human consumption."
• Responsible: the evidence is described honestly, including what's unknown. Risky: claims of guaranteed or dramatic results.
• Responsible: follow-up and labs are planned. Risky: a one-time sale with no check-in.

Monitoring and follow-up

Follow-up has two purposes: confirming the treatment is safe for you and deciding whether it's worth continuing. Your clinician will ask about side effects, review any repeat labs and compare progress against your starting point.

Monitoring catches problems that don't announce themselves. A growth hormone-releasing peptide might raise IGF-1 or blood sugar; a GLP-1 medicine can cause dehydration if nausea limits fluids; a new medicine elsewhere might interact. Small issues are easier to fix early.

How the bigger plan shapes the prescription

A peptide is rarely the whole answer. If labs show low iron, an underactive thyroid, prediabetes or a clear hormone deficiency, treating that usually comes first, because it addresses a known cause with stronger evidence.

Your clinician will also look at sleep, alcohol, activity and nutrition. A peptide prescribed into a plan that ignores those factors is less likely to help and harder to evaluate. When a peptide is added, it's best added on its own, so any change, good or bad, can be traced to it.

Why "set and forget" doesn't work

Your health changes over time. You might lose weight, start a new prescription, reach menopause or develop a condition that changes the risk-benefit balance. A peptide that made sense a year ago may not now.

Regular review also prevents drift, where a treatment continues out of habit without anyone asking whether it still helps. Planned stop-and-reassess points keep the plan honest.